 Subdural hematomas ( SDH) represent common neurosurgical problem associated with significant morbidity , mortality , and high recurrence rates. SDH incidence increases with age; numbers of patients affected by SDH continue to rise with our aging population and increasing number of people taking antiplatelet agents or anticoagulation. Medical and surgical SDH management remains a subject of investigation. Initial management of patients with concern for altered<symptom> mental<symptom> status<symptom> with or without trauma starts with Emergency Neurological<disease><symptom> Life Support ( ENLS) guidelines , with a focus on maintaining ICP < 22 mmHg , CPP > 60 mmHg , MAP 80-110 mmHg , and PaO